Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Classifica tra le azioni #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Prezzo delle azioni
$50.82
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$102.09M
Variazione (1 giorno)
1.90%
Variazione (1 anno)
-
Paese
US
Scambia Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Categoria

Healthcare
Il prezzo COAG con la capitalizzazione del mercato della B
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
COAG
$50.82
Capitalizzazione di mercato di Hemab Therapeutics Holdings, Inc. Common Stock(COAG)
Capitalizzazione di mercato: $102.09M
A partire dal August 2026, Hemab Therapeutics Holdings, Inc. Common Stock ha una capitalizzazione di mercato pari a $102.09M. Questo rende Hemab Therapeutics Holdings, Inc. Common Stock la 21709th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Hemab Therapeutics Holdings, Inc. Common Stock dal 2026 al 2026
COAG in paragone con la classifica dei più popolari stocks
Il prezzo per COAG Attivo B Capitalizzazione del mercato a B Risultati
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,594,322 $102.09M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,822.70%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,263,459 $102.09M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,775.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,072,162 $102.09M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,354.21%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,788,562 $102.09M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,305.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,390,338 $102.09M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,708.14%